CHE
Chemed Corporation · Healthcare · Medical - Care Facilities
Momentum inputs (comparable managers):
holder breadth +6.2% ·
share flow +13.8% ·
net new positions +5.9%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | +1 | 53.78K | $26.72M | +1 | −1 |
| Q2 2026 | 131 | +6 | 8.89M | $4.13B | +9 | −4 |
| Q1 2026 | 129 | 0 | 8.71M | $3.29B | +5 | −6 |
| Q4 2025 | 129 | -2 | 9.90M | $4.23B | +1 | −2 |
| Q3 2025 | 22 | -1 | 5.87M | $2.63B | n/a | −2 |
| Q2 2025 | 21 | +1 | 4.75M | $2.31B | +2 | −1 |
| Q1 2025 | 17 | 0 | 1.55M | $954.33M | +1 | −1 |
| Q4 2024 | 17 | +1 | 1.54M | $817.61M | +2 | −1 |
| Q3 2024 | 15 | 0 | 874.91K | $525.85M | n/a | n/a |
| Q2 2024 | 15 | n/a | 976.21K | $529.86M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 480.48K | n/a | $254.56M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 340.41K | +1.5% | $180.65M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passive) | 180.96K | +2.6% | $95.87M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Millennium Management ✦ | 140.78K | +163.3% | $74.58M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 5 | Point72 Asset Management ✦ | 103.03K | New | $54.59M | 0.2% | New | 1 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 80.67K | +18.0% | $42.74M | 0.1% | ▲ Add | 3 | SEC ↗ ×3 |
| 7 | Citadel Advisors ✦ | 77.14K | +197.4% | $40.87M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 47.10K | -1.4% | $24.95M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 25.29K | -22.4% | $13.40M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 10 | GAMCO Investors ✦ | 21.28K | -1.5% | $11.28M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 11 | Gotham Asset Management ✦ | 16.00K | -11.7% | $8.48M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 12 | Bridgewater Associates ✦ | 8.35K | -59.4% | $4.42M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 7.98K | -0.1% | $4.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 5.30K | -38.0% | $2.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 4.48K | -65.1% | $2.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Wellington Management ✦ | 2.24K | -30.8% | $1.19M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Marshall Wace ✦ | 1.17K | New | $618,276 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $54.59M | 0.2% |
| Marshall Wace | $618,276 | 0.0% |
Exited
| Capital World Investors | $25.24M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 486 holders, 12.67M shares, $4.47B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 2.00K sh · $1.03M
Officer, Director · 2.00K sh · $1.00M
Officer, Director · 2.00K sh · $1.08M
Officer · 1.00K sh · $541,040
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology